Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
5.345 USD | -4.55% | -16.07% | -61.59% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-61.59% | 470M | |
+64.32% | 62.59B | |
-1.28% | 41.18B | |
+44.76% | 40.29B | |
-8.93% | 27.9B | |
+13.33% | 26.21B | |
-21.62% | 19.09B | |
+4.69% | 13.08B | |
+25.76% | 12.26B | |
+28.21% | 12.05B |
- Stock Market
- Equities
- VERV Stock
- News Verve Therapeutics, Inc.
- Credit Suisse Lowers Verve Therapeutics' Price Target to $32 From $37, Maintains Neutral Rating